Agilent Technologies: Q4 Earnings Insights

Loading...
Loading...

Shares of Agilent Technologies A fell 2.53% in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share rose 10.11% over the past year to $0.98, which beat the estimate of $0.93.

Revenue of $1,483,000,000 higher by 8.49% from the same period last year, which beat the estimate of $1,400,000,000.

Guidance

Agilent Sees Q1 Adj. EPS $0.85-$0.88 vs $0.88 Est., Sales $1.42B-$1.43B vs $1.4B Est.; Sees FY21 Adj. EPS $3.57-$3.67 vs $3.68 Est., Sales $5.6B-$5.7B vs $5.67B Est.

Details Of The Call

Date: Nov 23, 2020

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.investor.agilent.com%2F&eventid=2626386&sessionid=1&key=606DDF936B1155263C494F86F6F156DF&regTag=&sourcepage=register

Loading...
Loading...

Recent Stock Performance

52-week high: $117.50

52-week low: $61.13

Price action over last quarter: Up 10.88%

Company Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations.

Loading...
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: Earnings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...